Announced Mon, 22 Jun · 12:16 IST
Trading window closure from June 30 ahead of Q1 results
Compliance View source PDF
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹65.10
prior close
₹66.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+2.0+1.8+1.8-7.0-6.6-9.8-16.5-18.0——
Up moveDown movePending
AI summary
Krebs Biochemicals has closed its trading window for insiders from close of business on June 30, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. The closure applies to promoters, directors, designated persons, their immediate relatives, and all connected persons, as required under SEBI insider trading rules. The board meeting date to consider Q1 results will be announced later.
Likely market impact
Routine compliance action; signals upcoming Q1 results announcement but no impact on shareholders or stock price.